Cargando…

ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan

Chitosan nanogel-coated polycaprolactone (PCL) fiber mat-based implant prototypes with tailored release of bone morphogenic protein 2 (BMP-2) are a promising approach to achieve implant-mediated bone regeneration. In order to ensure reliable in vitro release results, the robustness of a commercially...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundermann, Julius, Sydow, Steffen, Burmeister, Laura, Hoffmann, Andrea, Menzel, Henning, Bunjes, Heike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073737/
https://www.ncbi.nlm.nih.gov/pubmed/33921903
http://dx.doi.org/10.3390/pharmaceutics13040582
_version_ 1783684199021019136
author Sundermann, Julius
Sydow, Steffen
Burmeister, Laura
Hoffmann, Andrea
Menzel, Henning
Bunjes, Heike
author_facet Sundermann, Julius
Sydow, Steffen
Burmeister, Laura
Hoffmann, Andrea
Menzel, Henning
Bunjes, Heike
author_sort Sundermann, Julius
collection PubMed
description Chitosan nanogel-coated polycaprolactone (PCL) fiber mat-based implant prototypes with tailored release of bone morphogenic protein 2 (BMP-2) are a promising approach to achieve implant-mediated bone regeneration. In order to ensure reliable in vitro release results, the robustness of a commercially available ELISA for E. coli-derived BMP-2 and the parallel determination of BMP-2 recovery using a quantitative biological activity assay were investigated within a common release setup, with special reference to solubility and matrix effects. Without bovine serum albumin and Tween 20 as solubilizing additives to release media buffed at physiological pH, BMP-2 recoveries after release were notably reduced. In contrast, the addition of chitosan to release samples caused an excessive recovery. A possible explanation for these effects is the reversible aggregation tendency of BMP-2, which might be influenced by an interaction with chitosan. The interfering effects highlighted in this study are of great importance for bio-assay-based BMP-2 quantification, especially in the context of pharmaceutical release experiments.
format Online
Article
Text
id pubmed-8073737
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80737372021-04-27 ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan Sundermann, Julius Sydow, Steffen Burmeister, Laura Hoffmann, Andrea Menzel, Henning Bunjes, Heike Pharmaceutics Article Chitosan nanogel-coated polycaprolactone (PCL) fiber mat-based implant prototypes with tailored release of bone morphogenic protein 2 (BMP-2) are a promising approach to achieve implant-mediated bone regeneration. In order to ensure reliable in vitro release results, the robustness of a commercially available ELISA for E. coli-derived BMP-2 and the parallel determination of BMP-2 recovery using a quantitative biological activity assay were investigated within a common release setup, with special reference to solubility and matrix effects. Without bovine serum albumin and Tween 20 as solubilizing additives to release media buffed at physiological pH, BMP-2 recoveries after release were notably reduced. In contrast, the addition of chitosan to release samples caused an excessive recovery. A possible explanation for these effects is the reversible aggregation tendency of BMP-2, which might be influenced by an interaction with chitosan. The interfering effects highlighted in this study are of great importance for bio-assay-based BMP-2 quantification, especially in the context of pharmaceutical release experiments. MDPI 2021-04-19 /pmc/articles/PMC8073737/ /pubmed/33921903 http://dx.doi.org/10.3390/pharmaceutics13040582 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sundermann, Julius
Sydow, Steffen
Burmeister, Laura
Hoffmann, Andrea
Menzel, Henning
Bunjes, Heike
ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan
title ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan
title_full ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan
title_fullStr ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan
title_full_unstemmed ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan
title_short ELISA- and Activity Assay-Based Quantification of BMP-2 Released In Vitro Can Be Biased by Solubility in “Physiological” Buffers and an Interfering Effect of Chitosan
title_sort elisa- and activity assay-based quantification of bmp-2 released in vitro can be biased by solubility in “physiological” buffers and an interfering effect of chitosan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073737/
https://www.ncbi.nlm.nih.gov/pubmed/33921903
http://dx.doi.org/10.3390/pharmaceutics13040582
work_keys_str_mv AT sundermannjulius elisaandactivityassaybasedquantificationofbmp2releasedinvitrocanbebiasedbysolubilityinphysiologicalbuffersandaninterferingeffectofchitosan
AT sydowsteffen elisaandactivityassaybasedquantificationofbmp2releasedinvitrocanbebiasedbysolubilityinphysiologicalbuffersandaninterferingeffectofchitosan
AT burmeisterlaura elisaandactivityassaybasedquantificationofbmp2releasedinvitrocanbebiasedbysolubilityinphysiologicalbuffersandaninterferingeffectofchitosan
AT hoffmannandrea elisaandactivityassaybasedquantificationofbmp2releasedinvitrocanbebiasedbysolubilityinphysiologicalbuffersandaninterferingeffectofchitosan
AT menzelhenning elisaandactivityassaybasedquantificationofbmp2releasedinvitrocanbebiasedbysolubilityinphysiologicalbuffersandaninterferingeffectofchitosan
AT bunjesheike elisaandactivityassaybasedquantificationofbmp2releasedinvitrocanbebiasedbysolubilityinphysiologicalbuffersandaninterferingeffectofchitosan